| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 30,863 | | Cost of Revenue | 7,903 | | | Gross Profit | 22,960 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 14,923 | | Non Recurring | 2,849 | | Others | 459 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 4,729 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| | Earnings Before Interest And Taxes | 4,729 | | Interest Expense | 844 | | Income Before Tax | 3,885 | | Income Tax Expense | 1,170 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 2,716 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 2,716 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $2,716 |
|
0.83% Nasdaq 0.00%
Income Statement
